Clene Inc. (NASDAQ:CLNN) Receives Consensus Recommendation o

Clene Inc. (NASDAQ:CLNN – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the seven brokerages that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 12 month price target […]

Related Keywords

Davidj Matlin , Roth Mkm , John Henry Stevens , Silverarc Capital Management , Nasdaq , Investment Company Inc , Securities Exchange Commission , Cantor Fitzgerald , Clene Inc , Worth Venture Partners , Impact Partnership Wealth , Get Free Report , Director David , Exchange Commission , Director John Henry Stevens , Venture Partners , Capital Management , Bay Capital Management , Get Free , Multiple Sclerosis , Clene Daily , Clene , Nasdaq Clnn , Clnn , Medical , Ratings , Consensus ,